PEN-RAFA VK 500

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Kup teraz

Ulotka dla pacjenta Ulotka dla pacjenta (PIL)
04-12-2018

Składnik aktywny:

PHENOXYMETHYLPENICILLIN AS POTASSIUM

Dostępny od:

RAFA LABORATORIES LTD

Kod ATC:

J01CE02

Forma farmaceutyczna:

CAPLETS

Skład:

PHENOXYMETHYLPENICILLIN AS POTASSIUM 500 MG

Droga podania:

PER OS

Typ recepty:

Required

Wyprodukowano przez:

SANDOZ GmbH, AUSTRIA

Grupa terapeutyczna:

PHENOXYMETHYLPENICILLIN

Dziedzina terapeutyczna:

PHENOXYMETHYLPENICILLIN

Wskazania:

For susceptible microorganisms. To treat group A haemolytic infections of the upper respiratory tract using a twice daily regimen (1 G. bid in adults, 0.5 G bid in children).

Data autoryzacji:

2022-10-31

Ulotka dla pacjenta

                                1
Patient Leaflet According to the Pharmacists' Regulations
(Preparations) - 1986
This medicine requires a physician's prescription
Please read the entire leaflet carefully before using your medication
PEN-RAFA VK 500 CAPLETS
PEN-RAFA VK FORTE POWDER FOR PREPARING 60 ML SYRUP
COMPOSITION:
PEN-RAFA VK 500 CAPLETS
Active ingredient:
Each caplet contains: Penicillin V (as potassium) 500mg
Inactive ingredients:
Magnesium stearate, macrogol 6000, povidone, talc, hypromellose,
titanium dioxide
PEN-RAFA VK FORTE POWDER FOR PREPARING SYRUP
Active ingredient:
Each prepared teaspoon of syrup (5 ml) contains:
Penicillin V (as potassium) 250mg
Inactive ingredients:
Simethicone, saccharin sodium, sodium benzoate, citric acid anhydrous,
aspartame, carmellose
sodium, strawberry flavouring powdered, raspberry flavouring powdered,
trisodium citrate
anhydrous, sucrose
Each teaspoon contains 15 mg sodium, 1.5 g sugar.
THERAPEUTIC ACTIVITY
:
This medicine is indicated for the treatment of infections caused by
organisms susceptible
to penicillin.
THERAPEUTIC GROUP
:
An antibiotic of the penicillin group.
WHEN SHOULD THIS MEDICINE NOT BE USED?
Do not use this medicine if you are sensitive to penicillin,
cephalosporins or
penicillamine.
Do not use this medicine if you are sensitive to any of its
ingredients.
DO NOT TAKE THIS MEDICINE WITHOUT CONSULTING A DOCTOR BEFORE STARTING
TREATMENT:
If you are pregnant or breastfeeding; if you suffer or have suffered
in the past from
impaired function of the: respiratory tract (e.g. asthma), liver,
kidney/urinary tract,
digestive system (e.g. colitis), or if you suffer or have suffered in
the past from any kind
of allergy.
2
WARNINGS
:
_ _
The syrup contains the sweetener aspartame, which may harm patients
who have
phenylketonuria.
Do not use this medicine frequently, or for a long period, without
consulting a physician.
If you are sensitive to any foods or medications notify your physician
before starting
treatment.
DRUG INTERACTIONS
:
If you are taking any other medications or if you have recent
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta arabski 04-12-2018
Ulotka dla pacjenta Ulotka dla pacjenta hebrajski 04-12-2018

Wyszukaj powiadomienia związane z tym produktem

Zobacz historię dokumentów